These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1821239)

  • 21. Discontinuation reactions to alprazolam in panic disorder.
    Pecknold JC
    J Psychiatr Res; 1993; 27 Suppl 1():155-70. PubMed ID: 8145176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyponatremia-induced seizure during carbamazepine treatment.
    Holtschmidt-Täschner B; Soyka M
    World J Biol Psychiatry; 2007; 8(1):51-3. PubMed ID: 17366352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of panic disorder and comorbid substance abuse with divalproex sodium.
    Roberts JM; Malcolm R; Santos AB
    Am J Psychiatry; 1994 Oct; 151(10):1521. PubMed ID: 8092347
    [No Abstract]   [Full Text] [Related]  

  • 24. Valproate in anxiety and withdrawal syndromes.
    Roy-Byrne PP; Ward NG; Donnelly PJ
    J Clin Psychiatry; 1989 Mar; 50 Suppl():44-8. PubMed ID: 2494160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Response to "high anxiety".
    Piper A
    J Clin Psychopharmacol; 1994 Aug; 14(4):290-2. PubMed ID: 7962695
    [No Abstract]   [Full Text] [Related]  

  • 26. [Gabapentin treatment in a female patient with panic disorder and adverse effects under carbamazepine during benzodiazepine withdrawal].
    Himmerich H; Nickel T; Dalal MA; Müller MB
    Psychiatr Prax; 2007 Mar; 34(2):93-4. PubMed ID: 17124639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sexual dysfunction associated with diazepam but not with clonazepam.
    Balon R; Ramesh C; Pohl R
    Can J Psychiatry; 1989 Dec; 34(9):947-8. PubMed ID: 2611762
    [No Abstract]   [Full Text] [Related]  

  • 28. Use of anticonvulsants in benzodiazepine withdrawal.
    Pages KP; Ries RK
    Am J Addict; 1998; 7(3):198-204. PubMed ID: 9702287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dangerous interaction with nefazodone added to fluoxetine, desipramine, venlafaxine, valproate and clonazepam combination therapy.
    Benazzi F
    J Psychopharmacol; 1997; 11(2):190-1. PubMed ID: 9208383
    [No Abstract]   [Full Text] [Related]  

  • 30. A double-blind comparison of the effects of gradual withdrawal of lorazepam, diazepam and bromazepam in benzodiazepine dependence.
    Murphy SM; Tyrer P
    Br J Psychiatry; 1991 Apr; 158():511-6. PubMed ID: 1675901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychopharmacotherapy of panic disorder: 8-week randomized trial with clonazepam and paroxetine.
    Nardi AE; Valença AM; Freire RC; Mochcovitch MD; Amrein R; Sardinha A; Levitan MN; Nascimento I; de-Melo-Neto VL; King AL; de O E Silva AC; Veras AB; Dias GP; Soares-Filho GL; da Costa RT; Mezzasalma MA; de Carvalho MR; de Cerqueira AC; Hallak JE; Crippa JA; Versiani M
    Braz J Med Biol Res; 2011 Apr; 44(4):366-73. PubMed ID: 21344132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sodium valproate in benzodiazepine withdrawal.
    Apelt S; Emrich HM
    Am J Psychiatry; 1990 Jul; 147(7):950-1. PubMed ID: 2113360
    [No Abstract]   [Full Text] [Related]  

  • 33. Tapering clonazepam in patients with panic disorder after at least 3 years of treatment.
    Nardi AE; Freire RC; Valença AM; Amrein R; de Cerqueira AC; Lopes FL; Nascimento I; Mezzasalma MA; Veras AB; Sardinha A; de Carvalho MR; da Costa RT; Levitan MN; de-Melo-Neto VL; Soares-Filho GL; Versiani M
    J Clin Psychopharmacol; 2010 Jun; 30(3):290-3. PubMed ID: 20473065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sertraline treatment of panic disorder: results of a long-term study.
    Rapaport MH; Wolkow R; Rubin A; Hackett E; Pollack M; Ota KY
    Acta Psychiatr Scand; 2001 Oct; 104(4):289-98. PubMed ID: 11722304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clonazepam in the treatment of patients with recurrent panic attacks.
    Beaudry P; Fontaine R; Chouinard G; Annable L
    J Clin Psychiatry; 1986 Feb; 47(2):83-5. PubMed ID: 3944069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjunctive valproate in panic disorder patients with comorbid bipolar disorder or otherwise resistant to standard antidepressants: a 3-year "open" follow-up study.
    Perugi G; Frare F; Toni C; Tusini G; Vannucchi G; Akiskal HS
    Eur Arch Psychiatry Clin Neurosci; 2010 Oct; 260(7):553-60. PubMed ID: 20238120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clonazepam in the treatment of panic disorder and agoraphobia: a one-year follow-up.
    Pollack MH; Tesar GE; Rosenbaum JF; Spier SA
    J Clin Psychopharmacol; 1986 Oct; 6(5):302-4. PubMed ID: 3771814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Valproate treatment of panic disorder and lactate-induced panic attacks.
    Keck PE; Taylor VE; Tugrul KC; McElroy SL; Bennett JA
    Biol Psychiatry; 1993 Apr; 33(7):542-6. PubMed ID: 8513040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of divalproex sodium in patients with panic disorder and mood instability who have not responded to conventional therapy.
    Baetz M; Bowen RC
    Can J Psychiatry; 1998 Feb; 43(1):73-7. PubMed ID: 9494751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diazepam and propranolol in panic disorder and agoraphobia.
    Noyes R; Anderson DJ; Clancy J; Crowe RR; Slymen DJ; Ghoneim MM; Hinrichs JV
    Arch Gen Psychiatry; 1984 Mar; 41(3):287-92. PubMed ID: 6367691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.